<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for SRPT</title>
    <link />
    <description>Headlines for Sarepta Therapeutics</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Here's What Investing Giant George Soros Has Been Buying</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/22/heres-what-investing-giant-george-soros-has-been-b/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 22 May 2013 22:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Investing for Beginners</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/22/biotech-investing-for-beginners/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 22 May 2013 13:58:00 GMT</pubDate>
    </item>
    <item>
      <title>Sarepta Therapeutics' CEO Presents at 2013 UBS Global Healthcare Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1450501-sarepta-therapeutics-ceo-presents-at-2013-ubs-global-healthcare-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 21 May 2013 13:37:07 GMT</pubDate>
    </item>
    <item>
      <title>Sarepta Therapeutics Inc (SRPT): Today's Featured Drugs Winner</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11926339/1/sarepta-therapeutics-inc-srpt-todays-featured-drugs-winner.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 16 May 2013 17:00:00 GMT</pubDate>
    </item>
    <item>
      <title>2 BioPharma Catalyst Trades Set to Break-Out With One Strong Acquisition Target</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/insm/articles/186733/2-biopharma-catalyst-trades-set-to-break-out-with-one-strong-acquisition-target/2013-05-15.aspx</link>
      <author>Trefis</author>
      <pubDate>Wed, 15 May 2013 09:45:46 GMT</pubDate>
    </item>
    <item>
      <title>2 BioPharma Catalyst Trades And 1 Strong Acquisition Target Rumored To Be In Play</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1435081-2-biopharma-catalyst-trades-and-1-strong-acquisition-target-rumored-to-be-in-play.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 08:31:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Biotech Stocks With Potential</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1431871-3-biotech-stocks-with-potential.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 14 May 2013 08:16:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarin</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11919096/1/biotech-stock-mailbag-synta-zogenix-sarepta-amarin.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 10 May 2013 07:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Sarepta Therapeutics' CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1419841-sarepta-therapeutics-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 14:23:04 GMT</pubDate>
    </item>
    <item>
      <title>Leaders of &lt;I&gt;TheStreet's&lt;/I&gt; Drug Approval Contest</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11914517/1/leaders-of-ithestreetsi-drug-approval-contest.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 06 May 2013 09:21:00 GMT</pubDate>
    </item>
    <item>
      <title>April's Unhealthiest Stocks</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/04/aprils-unhealthiest-stocks/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 04 May 2013 08:00:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Biggest Biotech Crashes in April</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/01/3-biggest-biotech-crashes-in-april/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 01 May 2013 20:18:00 GMT</pubDate>
    </item>
    <item>
      <title>Sarepta Therapeutics Inc (SRPT): Today's Featured Drugs Winner</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11911463/1/sarepta-therapeutics-inc-srpt-todays-featured-drugs-winner.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Wed, 01 May 2013 17:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Stock Mailbag: ASCO, Sarepta, Cel-Sci and Hate Mail!</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11906065/1/biotech-stock-mailbag-asco-sarepta-cel-sci-and-hate-mail.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 26 Apr 2013 08:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's M&amp;A Chatter for Thursday April 25, 2013</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/media/cnbc/13/04/3531994/benzingas-m-a-chatter-for-thursday-april-25-2013.aspx</link>
      <author>Benzinga</author>
      <pubDate>Thu, 25 Apr 2013 19:46:48 GMT</pubDate>
    </item>
    <item>
      <title>Sarepta: Staying Long and Strong</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11905515/1/sarepta-staying-long-and-strong.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 25 Apr 2013 09:25:00 GMT</pubDate>
    </item>
    <item>
      <title>Sarepta Therapeutics: Irrational Exuberance</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1364651-sarepta-therapeutics-irrational-exuberance.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 25 Apr 2013 05:01:14 GMT</pubDate>
    </item>
    <item>
      <title>Edison Investment Research Believes FDA Approval for Sarepta's Eteplirsen Could Come Before Year-End</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/04/3525499/edison-investment-research-believes-fda-approval-for-sar.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 24 Apr 2013 11:56:18 GMT</pubDate>
    </item>
    <item>
      <title>Quickly Approaching Biopharma Catalyst Events</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/aveo/articles/182073/quickly-approaching-biopharma-catalyst-events/2013-04-24.aspx</link>
      <author>Trefis</author>
      <pubDate>Wed, 24 Apr 2013 09:01:26 GMT</pubDate>
    </item>
    <item>
      <title>Quickly Approaching Biopharma Catalyst Events</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1363881-quickly-approaching-biopharma-catalyst-events.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 24 Apr 2013 08:30:00 GMT</pubDate>
    </item>
  </channel>
</rss>
